Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells

Biomed Pharmacother. 2020 Sep:129:110413. doi: 10.1016/j.biopha.2020.110413. Epub 2020 Jun 20.

Abstract

Hepatic fibrosis is a pathophysiological process, which causes excessive extracellular matrix (ECM) deposition resulting from persistent liver damage. Myofibroblasts are the core cells that produce ECM. It is known that epithelial-mesenchymal transition (EMT) is not a simple transition of cells from the epithelial to mesenchymal state. Instead, it is a process, in which epithelial cells temporarily lose cell polarity, transform into interstitial cell-like morphology, and acquire migration ability. Hepatocytes, hepatic stellate cells, and bile duct cells are the types of intrahepatic cells found in the liver. They can be transformed into myofibroblasts via EMT and play important roles in the development of hepatic fibrosis through a maze of regulations involving various pathways. The aim of the present study is to explore the relationship between the relevant regulatory factors and the EMT signaling pathways in the various intrahepatic cells.

Keywords: Bile duct cells; Epithelial-mesenchymal transition; Hepatic fibrosis; Hepatic stellate cells; Hepatocytes; Mechanism research.

Publication types

  • Review

MeSH terms

  • Animals
  • Bile Ducts, Intrahepatic / metabolism
  • Bile Ducts, Intrahepatic / pathology
  • Cell Lineage
  • Cell Transdifferentiation*
  • Epithelial-Mesenchymal Transition*
  • Fibrosis
  • Hepatic Stellate Cells / metabolism
  • Hepatic Stellate Cells / pathology
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Humans
  • Liver / metabolism
  • Liver / pathology*
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / pathology*
  • Myofibroblasts / metabolism
  • Myofibroblasts / pathology
  • Signal Transduction